Vallon Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $11,387,000.
Profit Margin
| 2018 | 0 | -4.31M | |
|---|---|---|---|
| 2019 | 0 | -3.77M | |
| 2020 | 100K | -4.85M | -4856% |
| 2021 | 0 | -9.38M | |
| 2022 | 0 | -7.21M | |
| 2023 | 0 | -13.03M |
VLON Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 100K | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 100K | 0 | 0 |
Operating exp. | ||||||
Research and development | 3.23M | 1.17M | 5.18M | 3.70M | 1.88M | 3.51M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 11.38M | 6.92M | 9.25M | 4.88M | 3.15M | 4.31M |
Operating income | -11.38M | -6.92M | -9.25M | -4.78M | -3.15M | -4.31M |
Other income (expenses), net | -1.65M | -96K | -44K | -34K | -310.07K | 1.06K |
Income before tax | -13.03M | -7.02M | -9.30M | -4.82M | -3.46M | -4.31M |
Income tax expense | 0 | 192K | 77K | 34K | 310.07K | 1.06K |
Net income | -13.03M | -7.21M | -9.38M | -4.85M | -3.77M | -4.31M |
Earnings per share | ||||||
Basic EPS | -1.29 | -0.71 | -1.43 | -0.72 | -0.56 | -0.74 |
Diluted EPS | -1.29 | -0.71 | -1.43 | -0.72 | -0.56 | -0.74 |
| Data source | Data source | Data source | Data source |